Lazarus Pharmaceuticals, LLC is a biopharmaceutical holding company that utilizes an asset-centric business model of independent portfolio companies focused on maximizing the value of each drug candidate. The innovative drug candidates we develop will address underserved needs in gastroenterology, oncology, and other select therapeutic areas where we can achieve significant advances in patient quality of life.